This article was originally published in The Rose Sheet
Dawn Lepore appointed CEO and Chairman of the Board, effective Oct. 11, online retailer says. Lepore currently is vice chairman of technology, operations and administration for Charles Schwab, where she has worked for the past 21 years. During her tenure at Charles Schwab, exec played a "key role" in building firm's e-commerce business, company says. Lepore replaces former CEO Kal Raman, who stepped down in June, and Peter Neupert, who is retiring from drugstore.com's board of directors...
You may also be interested in...
Antoine Marchal, Franchise Head PCR Core Labs - BA Molecular Diagnostics at Qiagen outlines how NeuModx will strengthen its position in the infectious disease space.
Licensing agreements and bolt-on acquisitions to strengthen its R&D pipeline are still in Bayer’s sights as the COVID-19 pandemic and currency devaluations have led to the need for job cuts and substantial cost savings at the big pharma company.
Stay current on regulatory guidelines from around the world with Medtech Insight's Guidance Tracker. Twenty-seven guidance documents have been posted on the tracker since its last update.